European Commission authorises ViiV Healthcare Vocabria plus Rekambys for HIV treatment in adolescents Ruchika Sharma2 Feb 2025 1:30 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,...
GSK Depemokimab applications accepted for review in China, Japan for asthma with type 2 inflammation, CRSwNP Ruchika Sharma2 Feb 2025 11:30 AM ISTGSK plc has announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to...
GSK Depemokimab accepted for review by EMA for use in asthma with type 2 inflammation, CRSwNP Ruchika Sharma29 Jan 2025 2:30 PM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for...
GSK Shingrix new prefilled syringe presentation accepted for review by EMA Ruchika Sharma28 Jan 2025 10:15 AM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe...
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer Ruchika Sharma21 Jan 2025 1:30 PM ISTLondon: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy...
GSK to acquire IDRx for upto USD 1.15 billion Ruchika Sharma14 Jan 2025 12:45 PM ISTLondon: GSK plc has announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, clinical-stage...
GSK Shingrix new prefilled syringe presentation accepted for review by USFDA Ruchika Sharma11 Jan 2025 11:30 AM ISTGSK plc has announced that the US Food and Drug Administration (USFDA) has accepted for review the regulatory application of a prefilled syringe...
GSK bone cancer treatment gets USFDA Breakthrough Therapy Designation Ruchika Sharma7 Jan 2025 3:00 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation for GSK5764227...
GSK Nucala approved in China for treatment of adults with chronic rhinosinusitis with nasal polyps Ruchika Sharma4 Jan 2025 1:00 PM ISTLondon: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a monoclonal antibody...
Jemperli bags USFDA Breakthrough Therapy Designation for locally advanced dMMR/MSI-H rectal cancer: GSK Ruchika Sharma16 Dec 2024 1:30 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Jemperli...
Blenrep combo accepted for priority review in China in relapsed/refractory multiple myeloma: GSK Ruchika Sharma11 Dec 2024 1:30 PM ISTLondon: GSK plc has announced that the National Medical Products Administration (NMPA) of China has accepted for review a new drug application...
USFDA accepts GSK submission for use of Nucala in COPD Ruchika Sharma11 Dec 2024 11:30 AM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review, data from the MATINEE study to support the...
